Klin Farmakol Farm. 2009;23(2):53-57
Aim: The aim of the presented work was to analyse the prevalence of risky combinations of cardiovascular drugs. We assessed also patients
´ characteristics that increase the probability of their occurrence.
Methods: We enrolled 600 patients aged 65 years or more admitted to the Department of Internal Medicine of the Hospital in Povazska
Bystrica. To identify risky combinations of cardiovascular drugs the study of Vlahović-Palčevski et Bergman was applied. To define the
most important patient’s characteristics associated with the occurrence of risky combinations of cardiovascular medications, the binary
logistic regression model (SPSS for Windows, 15th version) was used.
Results: Risky combinations of cardiovascular drugs according to Vlahović-Palčevski and Bergman were found in 47 patients (7.8 %). The
combinations of angiotensin-converting enzyme (ACE) inhibitors with potassium sparing diuretics or with potassium supplements were
found to be the most common. Polypharmacy (odds ratio (OR) = 2.38; 95% confidence interval (CI) = 1.50–3.79), immobilization (OR =
1.87; 95% CI = 1.16–3.00) and atrial fibrillation (OR = 1.73; 95% CI = 1.13–2.64) were considered the most important patient’s characteristics
associated with prescription of risky combinations.
Conclusion: Elderly persons represent a vulnerable group regarding drug-drug interactions because of the common presence of polymorbidity
and polypharmacy. Present study is one of the studies that provide information on prescription of risky combinations of
cardiovascular drugs in elderly patients. The significant proportion of risky combinations observed in present study may be considered
rationally prescribed when laboratory markers and patients status is regularly monitored. Implementation of this topic within the framework
of continual medical education is needed.
Published: July 1, 2009 Show citation
Go to original source...
Go to PubMed...
Go to original source...
Go to PubMed...
Go to original source...
Go to PubMed...
Go to original source...
Go to PubMed...
Go to original source...
Go to PubMed...
Go to original source...
Go to PubMed...
Go to original source...
Go to PubMed...
Go to original source...
Go to PubMed...
Go to original source...
Go to PubMed...
Go to original source...
Go to PubMed...
Go to original source...
Go to PubMed...
Go to original source...
Go to PubMed...
Go to original source...
Go to PubMed...
Go to original source...
Go to PubMed...
Go to original source...
Go to PubMed...
Go to original source...
Go to PubMed...